Article
Inhibitors of Multidrug Resistance to Antitumor Agents (MDR)
1 Jan 2002
Abstract excerpt
Multidrug resistance is one of the main obstacles in the chemotherapy of cancer. Its inhibition by combination of chemosensitizers with antitumor compounds is a very active field of research, since safe and potent reversal agents would be beneficial for clinical use. Most modulators act by binding to membrane transport proteins (specially P-gp and MRP) and inhibiting their drug-effluxing activity, or by indirect...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
